中国妇幼健康研究
中國婦幼健康研究
중국부유건강연구
CHINESE JOURNAL OF MATERNAL AND CHILD HEALTH RESEARCH
2014年
6期
1012-1014
,共3页
产后贫血%和血胶囊%蔗糖铁注射液%疗效
產後貧血%和血膠囊%蔗糖鐵註射液%療效
산후빈혈%화혈효낭%자당철주사액%료효
postpartum anemia%Hexue capsule%Iron Sucrose injection%curative effect
目的：比较和血胶囊与蔗糖铁注射液治疗产后贫血的临床效果。方法选择湖北省十堰市妇幼保健院2013年1月至2014年1月间住院足月分娩且产后24h内确诊为贫血的98例产妇为研究对象，随机分为观察组和对照组，每组49例，观察组采用和血胶囊，对照组采用蔗糖铁注射液，比较两组患者疗效及副反应。结果观察组患者治疗后红细胞、血红蛋白和红细胞压积比治疗前显著升高（t值分别为11．99、22．71、9．08，均P＜0．05），对照组患者治疗后红细胞、血红蛋白和红细胞压积比治疗前显著升高（t值分别为2．91、10．01、2．57，均P＜0．05）。观察组治疗后红细胞、血红蛋白和红细胞压积比对照组显著升高（t值分别为14．16、15．55、7．10，均P＜0．05）。经治疗7日后，观察组总有效率为97．96％，对照组为79．59％，观察组显著高于对照组（χ2＝8．29，P＜0．05）。两组治疗期间不良反应发生率比较无显著性差异（χ2＝0．71，P＞0．05）。结论和血胶囊治疗产后贫血疗效明显优越，且用药方法简单、安全性高，值得临床广泛推广。
目的：比較和血膠囊與蔗糖鐵註射液治療產後貧血的臨床效果。方法選擇湖北省十堰市婦幼保健院2013年1月至2014年1月間住院足月分娩且產後24h內確診為貧血的98例產婦為研究對象，隨機分為觀察組和對照組，每組49例，觀察組採用和血膠囊，對照組採用蔗糖鐵註射液，比較兩組患者療效及副反應。結果觀察組患者治療後紅細胞、血紅蛋白和紅細胞壓積比治療前顯著升高（t值分彆為11．99、22．71、9．08，均P＜0．05），對照組患者治療後紅細胞、血紅蛋白和紅細胞壓積比治療前顯著升高（t值分彆為2．91、10．01、2．57，均P＜0．05）。觀察組治療後紅細胞、血紅蛋白和紅細胞壓積比對照組顯著升高（t值分彆為14．16、15．55、7．10，均P＜0．05）。經治療7日後，觀察組總有效率為97．96％，對照組為79．59％，觀察組顯著高于對照組（χ2＝8．29，P＜0．05）。兩組治療期間不良反應髮生率比較無顯著性差異（χ2＝0．71，P＞0．05）。結論和血膠囊治療產後貧血療效明顯優越，且用藥方法簡單、安全性高，值得臨床廣汎推廣。
목적：비교화혈효낭여자당철주사액치료산후빈혈적림상효과。방법선택호북성십언시부유보건원2013년1월지2014년1월간주원족월분면차산후24h내학진위빈혈적98례산부위연구대상，수궤분위관찰조화대조조，매조49례，관찰조채용화혈효낭，대조조채용자당철주사액，비교량조환자료효급부반응。결과관찰조환자치료후홍세포、혈홍단백화홍세포압적비치료전현저승고（t치분별위11．99、22．71、9．08，균P＜0．05），대조조환자치료후홍세포、혈홍단백화홍세포압적비치료전현저승고（t치분별위2．91、10．01、2．57，균P＜0．05）。관찰조치료후홍세포、혈홍단백화홍세포압적비대조조현저승고（t치분별위14．16、15．55、7．10，균P＜0．05）。경치료7일후，관찰조총유효솔위97．96％，대조조위79．59％，관찰조현저고우대조조（χ2＝8．29，P＜0．05）。량조치료기간불량반응발생솔비교무현저성차이（χ2＝0．71，P＞0．05）。결론화혈효낭치료산후빈혈료효명현우월，차용약방법간단、안전성고，치득림상엄범추엄。
Objective To compare the clinical effect of Hexue capsule and Iron Sucrose injection on postpartum anemia .Methods From January 2013 to January 2014 98 cases diagnosed with postpartum anemia 24h after delivery in Shiyan Maternal and Child Health Care Hospital of Hubei Province were selected and randomly divided into observation group and control group , and each group had 49 cases. Hexue capsule was provided for the observation group , while Iron Sucrose injection was given to the control group .The curative effect and side reaction were observed and compared between two groups .Results The red blood cell , hemoglobin and hematocrit in the observation group were significantly increased compared with those prior to treatment ( t value was 11.99, 22.71 and 9.08, respectively, all P<0.05), and those in the control group were also significantly increased compared to those prior to treatment (t value was 2.91, 10.01 and 2.57, respectively, all P<0.05).The red blood cell, hemoglobin and hematocrit in the observation group were significantly increased compared to the control group (t value was 14.16, 15.55 and 7.10, respectively, all P<0.05).After treatment for 7 days, the total effective rate of the observation group (97.96%) was significantly higher than that of the control group (79.59%) (χ2 =8.29, P<0.05).There was no significant difference in the incidence of side reaction between two groups (χ2 =0.71, P>0.05).Conclusion Hexue capsule is obviously superior to Iron Sucrose injection in the treatment of postpartum anemia , so it is worthy of clinical application for simple method and high safety .
